At a glance
ClinicalIndex Comparison RecordN/ACompleted· 156 enrolled
Drug / intervention
AtriClipdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long-term Follow-up on LAA Exclusion Using AtriClip, VCLIP Post-Market Study, CLINICAL TRIAL PROTOCOL: CP-2021-03
In Brief
A clinical study evaluating AtriClip for Left Atrial Appendage Absent. Completed, enrolled 156 participants across 11 sites.
Detailed Summary
Retrospective-prospective, multi-center, non-randomized, unblinded, post-market study to evaluate the long-term performance and safety of AtriClip® FLEX-V LAA and PRO•V LAA Exclusion devices for exclusion of the left atrial appendage of the heart during concomitant cardiac procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeft Atrial Appendage Absent
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedNov 2021
Enrollment StartJan 2022
Primary CompletionMar 2023
Study CompletionJul 2024
TodayJul 2026
First PostedNov 1, 2021
Enrollment StartJan 27, 2022
Primary CompletionMar 31, 2023
Study CompletionJul 22, 2024
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.7 years ago
Interventions
AtriClipdevice
Received AtriClip for exclusion of left atrial appendage during concomitant cardiac procedure